BW Communities

author-image

C H Unnikrishnan

Author

Unnikrishnan is currently Senior Associate Editor with BW Businessworld at its Mumbai Bureau. During his two decades long journalistic career, he has received several media awards and recognitions. His articles on healthcare, life sciences and intellectual property rights (IPR) have been republished by several international blogs and journals. 

Latest Articles By C H Unnikrishnan

Raymond's 4Q Net Up 162 Per Cent On High Textile, Garment Sales

The increased profitability in the apparel business during the quarter was despite additional investments for the expansion of its retail network, the company said

Read More
Health Care At Home Plans To Raise Rs 100 Crore To Expand Footprint

The company, which is planning a pan India presence by setting up its teams in almost all cities in the next 4 to 5 years, would also double its staff strength to some 1,200 by 2020

Read More
Playing Cat And Mouse

This situation is unique to India, where sales growth of companies is closely connected to brand launches

Read More
Thyrocare IPO To Be Priced Between Rs 409 - Rs 446

The Rs 480 crore initial public offer of the leading diagnostics chain, which is valued at Rs 2400 crore, will open on 27 April

Read More
Cadila Gets Negative US FDA Observations For Matoda SEZ Unit

The American regulator had in January issued similar notice to the company's Moraiya manufacturing unit

Read More
Ajanta Pharma: Turn Around Man

A rank holder in the 1984 batch of the Institute of Chartered Accountants, Agrawal started his career with IDBI, then one of the leading financial institutions in the country.

Read More
Serial Entrepreneur Raman Kumar Launches New App-based Lending Platform CASHe In India

CASHe, a new smart phone platform, will be providing immediate cash loans to young professionals based on their social profile, merit and earning potential using its proprietary algorithms and machine learning

Read More
Sahara, Kingfisher Recovery Plan: All That Glitters Is Not Gold

The recovery actions spelt out early this week in two controversial cases of economic offence related to Sahara Group and Kingfisher Airlines are unlikely to fetch the desired outcome as the sales of the assets are neither easy nor adequately compensating

Read More
Ajanta Pharma: A Dose Of Strong Medicine

Lacking the financial or operational muscle to compete with pharma giants, Ajanta focused on first-of-its-kind drugs to script a turnaround

Read More
TCS: Making Sense Of It

He has taken TCS well ahead of local and global peers in growth and valuation and is now focusing on the digital space

Read More

Subscribe to our newsletter to get updates on our latest news